1921
Volume 100, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Data regarding cardiac involvement in enteric fever among travelers are scarce. In this retrospective study, 59 patients were hospitalized with enteric fever during 2004–2017 and 28 had cardiac workups. Among those, four had evidence of cardiac involvement, including clinical myocarditis, electrocardiogram changes, or troponin elevation. Cardiac involvement was higher among patients infected with Typhi than with Paratyphi A ( = 0.08), with a significant relative risk of 6 (95% CI: 1.15–31.22, = 0.03). Time from symptoms onset to effective treatment was longer for patients with cardiac involvement (13 versus 7.15 days, < 0.05). It seems that cardiac involvement in enteric fever is not uncommon in travelers. Such involvement seems to be more common in patients with delay of effective treatment to the second week of illness. Although fatal or complicated cases are rare in travelers, the cardiac complication may be an important contributor to morbidity and mortality in this group.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0775
2019-03-11
2020-11-30
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/5/tpmd180775.html?itemId=/content/journals/10.4269/ajtmh.18-0775&mimeType=html&fmt=ahah

References

  1. Meltzer E, Stienlauf S, Leshem E, Sidi Y, Schwartz E, 2014. A large outbreak of Salmonella Paratyphi A infection among Israeli travelers to Nepal. Clin Infect Dis 58: 359364.
    [Google Scholar]
  2. Prabha A, Mohanan, Pereira P, Raghuveer CV, 1995. Myocarditis in enteric fever. Indian J Med Sci 49: 2831.
    [Google Scholar]
  3. Mainzer F, 1947. Electrocardiographic study of typhoid myocarditis. Br Heart J 9: 145153.
    [Google Scholar]
  4. Huang DB, DuPont HL, 2005. Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection. Lancet Infect Dis 5: 341348.
    [Google Scholar]
  5. Mellon G, Eme AL, Rohaut B, Brossier F, Epelboin L, Caumes E, 2017. Encephalitis in a traveller with typhoid fever: efficacy of corticosteroids. J Travel Med 24.
    [Google Scholar]
  6. Caforio AL et al., 2013. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34: 26362648, 2648a–2648d.
    [Google Scholar]
  7. Palombo M, Margalit-Yehuda R, Leshem E, Sidi Y, Schwartz E, 2013. Near-fatal myocarditis complicating typhoid fever in a traveler returning from Nepal. J Travel Med 20: 329332.
    [Google Scholar]
  8. Connor BA, Schwartz E, 2005. Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 5: 623628.
    [Google Scholar]
  9. Drewett G, Leder K, 2016. Infectious disease following travel to developed regions: a snapshot of presentations to an Australian travel medicine clinic. J Travel Med 23.
    [Google Scholar]
  10. Ackers ML, Puhr ND, Tauxe RV, Mintz ED, 2000. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 283: 26682673.
    [Google Scholar]
  11. Bobin AN, Klochkov ND, Bogomolova NV, 1993. Complications and the proximate causes of death in typhoid [in Russian]. Voen Med Zh: 4952.
    [Google Scholar]
  12. Lv X, Wang H, 2016. Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res 3: 30.
    [Google Scholar]
  13. Maeder M, Fehr T, Rickli H, Ammann P, 2006. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129: 13491366.
    [Google Scholar]
  14. Spies C, Haude V, Fitzner R, Schroder K, Overbeck M, Runkel N, Schaffartzik W, 1998. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113: 10551063.
    [Google Scholar]
  15. Shlim DR, Schwartz E, Eaton M, 1995. Clinical importance of Salmonella Paratyphi A infection to enteric fever in Nepal. J Travel Med 2: 165168.
    [Google Scholar]
  16. Meltzer E, Sadik C, Schwartz E, 2005. Enteric fever in Israeli travelers: a nationwide study. J Travel Med 12: 275281.
    [Google Scholar]
  17. Vollaard AM, Ali S, Widjaja S, Asten HA, Visser LG, Surjadi C, van Dissel JT, 2005. Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Trans R Soc Trop Med Hyg 99: 440450.
    [Google Scholar]
  18. Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL, 2015. Typhoid fever. Lancet 385: 11361145.
    [Google Scholar]
  19. Zmora N, Shrestha S, Neuberger A, Paran Y, Tamrakar R, Shrestha A, Madhup SK, Bedi TRS, Koju R, Schwartz E, 2018. Open label comparative trial of mono versus dual antibiotic therapy for typhoid fever in adults. PLoS Negl Trop Dis 12: e0006380.
    [Google Scholar]
  20. Butler T, Girard AE, 1993. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice. J Antimicrob Chemother 31: 313319.
    [Google Scholar]
  21. Oey M, Malhotra P, 2016. Azithromycin and ceftriaxone combination treatment for relapsed Salmonella Paratyphi A bacteraemia. J Travel Med 23: tav032.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0775
Loading
/content/journals/10.4269/ajtmh.18-0775
Loading

Data & Media loading...

  • Received : 24 Sep 2018
  • Accepted : 21 Jan 2019
  • Published online : 11 Mar 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error